View of Janus Kinase Inhibitors Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis: A Systematic Review

Return to Article Details Janus Kinase Inhibitors Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis: A Systematic Review Download Download PDF